Skip to main content
Signal8

Inogen Inc (INGN)

Inogen, Inc. operates as a medical technology enterprise dedicated to designing, fabricating, and distributing oxygen concentration equipment. These cutting-edge devices are engineered to provide continuous oxygen support for patients managing persistent respiratory conditions. The company's diverse product range features the popular portable Inogen One, which efficiently draws oxygen from the surrounding atmosphere to offer an independent supply, alongside stationary Inogen At Home concentrators, Tidal Assist Ventilators, and various associated accessories. Inogen serves a broad clientele, including individual patients, medical professionals, and insurance providers, both domestically in the United States and globally. Furthermore, the company facilitates direct equipment rentals to patients. Founded in 2001, Inogen, Inc. is headquartered in Goleta, California.

Sector: Orthopedic, Prosthetic & Surgical Appliances & Supplies

Industry: Medical - Devices

Inogen, Inc. logo

Inogen, Inc.

NASDAQ:INGNHealthcare
-5.51%$6.86
AH$6.86+0.00%vs close
Mkt Cap$182.05M
Float23.09M
O/S26.54M
Vol
$ Vol
RVOL
Inst Own72.1%
SI6.6%
Earnings
Dilution
Phase Distribution
5 lead-sponsored trials·0 active·4 completed
Not applicable5
(1 more as collaborator)
Status Overview
Not yet recruiting1
Completed4

Trials need funding. See this company's dilution risk and cash position.

Clinical Trials
Sponsor role
Status
  • Not applicable
    Completed

    Portable Oxygen Concentrator (POC) Versus Standard of Care in Long-COVID: Randomized Crossover Exploratory Pilot Study.

    Inogen One® G4

    COVID-19

    Enrollment
    21
    Start
    Jun 2022
    Primary Completion
    Mar 2023
    Completion
    Mar 2023
    NCT05212831
  • Not applicable
    Completed

    Portable Oxygen Concentrator in Non-hospitalized Patients With Chronic Heart Failure

    Inogen Rove 6 Portable Oxygen Concentrator

    Heart Failure

    Enrollment
    20
    Start
    Oct 2023
    Primary Completion
    Nov 2023
    Completion
    Nov 2023
    NCT05719363
  • Not applicable
    Completed

    Evaluation of POC Pulse-dose Demand Oxygen Delivery for Nocturnal Hypoxemia

    InogenOne Rove 6 Portable Oxygen Concentrator

    Nocturnal Hypoxemia

    Enrollment
    20
    Start
    Oct 2023
    Primary Completion
    Dec 2023
    Completion
    Dec 2023
    NCT06000332
  • Not applicable
    Completed

    Acute Effects of Supplemental Oxygen on Memory Testing in Healthy Adult Volunteers

    Cross Over Assignment Supplemental Oxygen and Supplemental Air

    Cognition

    Enrollment
    40
    Start
    May 2024
    Primary Completion
    Oct 2024
    Completion
    Oct 2024
    NCT06555484
  • Not applicable
    Not yet recruiting

    Simeox 200 US Study

    Intermittent intrapulmonary deflation

    Bronchiectasis, Mucus; Plug

    Enrollment
    35
    Start
    Feb 2026est.
    Primary Completion
    May 2026est.
    Completion
    Jun 2026est.
    NCT07443124